Sunday, February 8, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Ratings and Price Targets for Oracle Hold Buy and Growth Expectations

Elaine Mendonca by Elaine Mendonca
March 12, 2024
in Breaking News
0
Tokenized-security-technology
0
SHARES
3
VIEWS
Share on FacebookShare on Twitter

Stifel analyst Brad Reback has decided to keep his Hold rating on Oracle (NYSE: ORCL) while increasing the price target from $100 to $120. This change in target price indicates Stifel’s positive outlook on Oracle’s future performance.

On the other hand, Jefferies has reiterated their ‘buy’ recommendation on Oracle, with the price target now raised from $145 to $150. This shows Jefferies’ confidence in Oracle’s potential for growth.

As of March 12, 2024, the market consensus for Oracle remains at a “Hold” rating, based on the average recommendation of 40 analysts.

Oracle Corporation (ORCL) Stock Surges 10.59% on March 12, 2024 with Strong Performance in the Market

On March 12, 2024, Oracle Corporation (ORCL) showed strong performance in the stock market, with its shares trading near the top of its 52-week range and above its 200-day simple moving average. The price momentum for ORCL was positive, indicating a bullish trend in the stock.

The price of ORCL shares increased significantly on March 12, with a rise of $12.09 since the market last closed. This represented a 10.59% increase in the stock price, reflecting strong investor interest and confidence in the company.

ORCL opened at $126.49 on March 12, which was $12.36 higher than its previous close. This opening price signaled a strong start for the stock and set a positive tone for the trading day ahead.

Oracle Corporation (ORCL) Reports Strong Financial Results with Revenue and Net Income Growth

On March 12, 2024, Oracle Corporation (ORCL) saw a positive performance in its stock as the company reported strong financial results for the past year and the most recent quarter. According to data from CNN Money, Oracle’s total revenue for the past year was $49.95 billion, representing a 17.7% increase compared to the previous year. In the most recent quarter, total revenue was reported at $12.94 billion, which is a 3.92% increase from the previous quarter.

Net income for Oracle also showed significant growth, with the company reporting a net income of $8.50 billion for the past year, a 26.59% increase from the previous year. In the second quarter, net income was $2.50 billion, showing a 3.43% increase from the previous quarter.

Earnings per share (EPS) for Oracle also saw a positive trend, with the company reporting an EPS of $3.07 for the past year, a 27.5% increase from the previous year. In the most recent quarter, EPS was reported at $0.89, showing a 3.65% increase from the previous quarter.

Tags: ORCL
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Transportation parcels

Blade Air Mobility Inc Reenters Trading Scene with Updated Financial Data

Finance_Assets (2)

Repay Holdings Explores Acquisition by Private Equity Firms in Competitive Payments Industry

Mining technology

Phunware Inc to Release FourthQuarter Financial Results and Discuss Future Plans at ROTH Conference

Recommended

FCBC stock news

Impax Asset Management Group plc Reduces Stake in Snap Inc. as Insiders Sell Off Shares

2 years ago
The Trade Desk Stock

The Trade Desk: A Market Conundrum of Conflicting Signals

3 months ago
Intel Stock

US Government Holds Massive Intel Share Position, Creating Market Uncertainty

5 months ago
Nuvalent Stock

Nuvalent Shares Surge on Promising Clinical Trial Results

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Tax Clarity and Sector Optimism Bolster Outlook for Chicago Atlantic

RBB Bancorp Reports Strong Asset Quality Improvement and Strategic Capital Review

Cassava Sciences Confirms Alzheimer Drug Failure and Faces Regulatory Delays

DroneShield Shares Face Headwinds Despite Record Performance

Rock Tech Lithium: Investors Await the Final Go-Ahead

Puma Biotechnology Sets Date for Full-Year Financial Disclosure

Trending

KemPharm Stock
Analysis

Zevra Therapeutics Advances Rare Disease Portfolio with New Data and Strategic Expansion

by Kennethcix
February 8, 2026
0

Zevra Therapeutics continues to build its profile as a dedicated rare disease company. Recent clinical data presentations...

Oak Valley Stock

Oak Valley Bancorp Surpasses $2 Billion Milestone with Record Annual Profit

February 8, 2026
SuRo Capital Stock

SuRo Capital Sharpens Focus on AI Infrastructure Investments

February 8, 2026
Chicago Atlantic Real Estate Finance Stock

Tax Clarity and Sector Optimism Bolster Outlook for Chicago Atlantic

February 8, 2026
RBB Stock

RBB Bancorp Reports Strong Asset Quality Improvement and Strategic Capital Review

February 8, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Zevra Therapeutics Advances Rare Disease Portfolio with New Data and Strategic Expansion
  • Oak Valley Bancorp Surpasses $2 Billion Milestone with Record Annual Profit
  • SuRo Capital Sharpens Focus on AI Infrastructure Investments

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com